Article info

Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis

Authors

  1. Correspondence to Professor Josef S Smolen, Rheumatology, Medical University of Vienna, Vienna, Austria; josef.smolen{at}meduniwien.ac.at
View Full Text

Citation

Lopez-Romero P, de la Torre I, Haladyj E, et al
Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis

Publication history

  • Received August 10, 2021
  • Accepted February 1, 2022
  • First published February 22, 2022.
Online issue publication 
April 08, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.